Solutions
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Inquiry

Cell Engineering Service

Cell engineering and genetic engineering together represent the latest development frontier of biotechnology and play an increasingly important role in the field of biopharmaceuticals. At our company, we recognize the transformative potential of cell engineering. By altering cells at the molecular level, we propel the development of effective treatments, biotechnological tools, and medical advancements. We offer a full suite of cell engineering services to support your research and development of rare disease therapies.

Introduction to Cell Engineering

Cell Engineering, an avant-grade field of study in biological sciences, employs the principles of biology and engineering to manipulate living cells' properties. This innovative and multi-disciplinary realm essentially modifies cellular components to elicit specific functions or traits necessary for translational research, biopharmaceuticals, or clinical applications. Cell engineering involves a wide range of fields. According to technical classification, it roughly includes cell fusion technology, cell disassembly technology, chromosome technology, gene transfer technology, embryo transplantation technology, and cell tissue culture technology. According to different cell types, cell engineering can be divided into plant and animal cell engineering.

Fig.1 Current cell engineering strategies. (Liang, Kaini, and Yanan Du, 2021)Fig.1 Current cell engineering strategies. (Liang, Kaini, and Yanan Du, 2021)

Cell Engineering for Rare Diseases

Cell engineering plays a seminal role in combating rare and genetic diseases. Standard medical procedures often leave such pathologies neglected due to their rarity and the vast heterogeneity among patients. Cell engineering acts as a beacon of hope in this domain, providing ground-breaking and tailored therapies. From the intimate study of patient-specific iPSCs (induced pluripotent stem cells) to the more recent breakthroughs in CRISPR-Cas9 gene editing technology, the scope of cell engineering in the treatment of rare diseases is expansive.

Table 1 Advances in engineering cells for rare disease diagnosis. (Zhao, Ninglin, et al., 2023)

Rare Disease Biomarker Reporter Diagnostics feature
Diabetes Glucose Fluorescence Glucose-responsive integrase expression cassette (PCpxP-integrase-pA) that expresses the green fluorescent protein (GFP) for glycosuria testing.
Vibrio cholera infection Cholera autoinducer 1 (CAI-1) Colorimetric enzymatic reaction CqsS-NisK quorum sensing block for cholera autoinducer 1 (CAI-1) detection.

Our Services

Through years of service and extensive expertise, our company is committed to the construction of cell engineering platforms and provides you with customized cell engineering services to deliver general cell lines and induced pluripotent stem cells (iPSCs) used for rare disease preclinical studies. We offer strict quality control and competitive prices and deliver cell products in a short time.

  • Workflow of Cell Construction
Gene Editing

Gene Editing

-Knock-ins (KI)
-Gene knockouts (KO)
-Point mutations (PM)
-Overexpression (OE)

Cell Transfection

Cell Transfection

-Standard (lipid/nanoparticle)
-Electroporation
-Transposon
-Viral vector
-mediated transduction

Cell Screening

Cell Screening

-Flow cytometry
-Western blot
-PA-HPLC
-ELISA
-ClonePix

Cell Validation

Cell Validation

-Thaw test
-Mycoplasma
-Clonal stability
-Receptor density estimation

  • Target Types

    Providing a variety of cell targeting services to achieve precise cell targeting.

    • Enzymes
    • Antibodies
    • Membrane/structural proteins
    • Reporter proteins

Why Choose Us?

Why Choose Us

As an integrated CRO, our company has the capabilities and resources to provide professional communication and problem-solving support to ensure that we can quickly respond to the changing needs of your rare disease research projects. We provide comprehensive cell engineering services to leading and emerging biopharmaceutical companies and scientific research institutions. If you are interested in our services, please feel free to contact us for more details and quotation information of related services.

References

  • Liang, Kaini, and Yanan Du. "Cell engineering techniques improve pharmacology of cellular therapeutics." Biomaterials and Biosystems 2 (2021): 100016.
  • Zhao, Ninglin, et al. "Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development." Signal Transduction and Targeted Therapy 8.1 (2023): 112.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Related Disease Solutions

Copyright © Protheragen. All rights reserves.